3-(Dipropylamino)-5-hydroxybenzofuro[2,3-f]quinazolin-1(2H)-one (DPA-HBFQ-1) plays an inhibitory role on breast cancer cell growth and progression.
第一作者:
Pietro,Rizza
第一单位:
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036, Arcavacata di Rende, Italy.
作者:
医学主题词
抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);苯呋喃类(Benzofurans);乳腺肿瘤(Breast Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);周期素依赖激酶抑制剂p21(Cyclin-Dependent Kinase Inhibitor p21);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);女(雌)性(Female);人类(Humans);启动区, 遗传(Promoter Regions, Genetic);喹唑啉酮类(Quinazolinones);他莫昔芬(Tamoxifen);拓扑异构酶I抑制剂(Topoisomerase I Inhibitors);拓扑异构酶II抑制剂(Topoisomerase II Inhibitors);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.1016/j.ejmech.2015.11.004
PMID
26599533
发布时间
2015-12-08
- 浏览22
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



